FDA Inspection 1165879 — Children's Hospital of Alabama Blood Bank

Children's Hospital of Alabama Blood Bank — FEI 1072228

The FDA completed an inspection of Children's Hospital of Alabama Blood Bank on March 25, 2022 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 25, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Birmingham, AL (United States)